A Subgroup Reanalysis of the Efficacy of Bufei Huoxue Capsules in Patients With “Long‐Covid‐19”

ABSTRACT Bufei huoxue capsules (BFHX), manufactured products of traditional Chinese medicine, have demonstrated anti‐inflammatory properties and efficacy against chronic pulmonary diseases and COVID‐19. This study was designed to further determine the clinical efficacy of BFHX in diverse patient sub...

Полное описание

Библиографические подробности

Главные авторы:	Chi Hou, Yue Xing, Yuqin Chen, Tingping Wang, Jingjing Qi, Xiaoqing Jia, Xiansheng Zeng, Jianling Bai, Wenju Lu, Yu Deng, Bihua Zhong, Yongxia Lei, Yilin Chen, Zhan Lian, Haohao Zhou, Junping Yan, Xuejiao Yang, Hao Yu, Jiawei Zhou, Lixia Qiu, Yunliang Zhai, Wanli Geng, Nanshan Zhong, Chunli Liu, Jian Wang
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2025-04-01
Серии:	Pulmonary Circulation
Предметы:	bufei huoxue capsules post‐acute COVID‐19 syndrome subgroup reanalysis symptom recovery traditional Chinese medicine
Online-ссылка:	https://doi.org/10.1002/pul2.70084
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!